π’
|
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.
9 auth.
D. Ponti,
Aurora Costa,
N. Zaffaroni,
G. Pratesi,
G. Petrangolini,
D. Coradini,
...
S. Pilotti,
M. Pierotti,
M. Daidone
|
10 |
2005 |
10 π’
|
π
|
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
15 auth.
M. Cordenonsi,
Francesca Zanconato,
L. Azzolin,
M. Forcato,
A. Rosato,
C. Frasson,
M. Inui,
Marco Montagner,
A. Parenti,
A. Poletti,
...
M. Daidone,
S. Dupont,
G. Basso,
S. Bicciato,
S. Piccolo
|
10 |
2011 |
10 π
|
π
|
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
28 auth.
Y. Hoshida,
A. Villanueva,
M. Kobayashi,
J. Peix,
Derek Y. Chiang,
Amy L. Camargo,
Supriya Gupta,
Jamie M Moore,
Matthew J Wrobel,
Jim Lerner,
Michael Reich,
J. Chan,
J. Glickman,
K. Ikeda,
M. Hashimoto,
...
G. Watanabe,
M. Daidone,
S. Roayaie,
M. Schwartz,
S. Thung,
H. Salvesen,
S. Gabriel,
V. Mazzaferro,
J. Bruix,
S. Friedman,
H. Kumada,
J. Llovet,
T. Golub
|
10 |
2008 |
10 π
|
π
|
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
12 auth.
M. Bernardo,
N. Zaffaroni,
F. Novara,
A. Cometa,
M. Avanzini,
A. Moretta,
...
D. Montagna,
R. Maccario,
R. Villa,
M. Daidone,
O. Zuffardi,
F. Locatelli
|
9 |
2007 |
9 π
|
π
|
A MicroRNA Targeting Dicer for Metastasis Control
14 auth.
Graziano Martello,
A. Rosato,
F. Ferrari,
A. Manfrin,
M. Cordenonsi,
S. Dupont,
E. Enzo,
V. Guzzardo,
M. Rondina,
Thomas Spruce,
...
A. Parenti,
M. Daidone,
S. Bicciato,
S. Piccolo
|
9 |
2010 |
9 π
|
π
|
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.
9 auth.
R. Silvestrini,
S. Veneroni,
M. Daidone,
E. Benini,
P. Boracchi,
M. Mezzetti,
...
G. di Fronzo,
F. Rilke,
U. Veronesi
|
8 |
1994 |
8 π
|
π
|
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
19 auth.
S. Loi,
B. Haibe-Kains,
C. Desmedt,
P. Wirapati,
F. Lallemand,
A. Tutt,
Cheryl Gillet,
P. Ellis,
K. Ryder,
J. Reid,
...
M. Daidone,
M. Pierotti,
E. Berns,
M. Jansen,
J. Foekens,
M. Delorenzi,
Gianluca Bontempi,
M. Piccart,
C. Sotiriou
|
8 |
2008 |
8 π
|
π
|
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
13 auth.
P. Gandellini,
M. Folini,
Nicole Longoni,
M. Pennati,
M. Binda,
M. Colecchia,
R. Salvioni,
R. Supino,
R. Moretti,
P. Limonta,
...
R. Valdagni,
M. Daidone,
N. Zaffaroni
|
8 |
2009 |
8 π
|
π
|
Rational design of shepherdin, a novel anticancer agent.
13 auth.
J. Plescia,
Whitney Salz,
F. Xia,
M. Pennati,
N. Zaffaroni,
M. Daidone,
M. Meli,
T. Dohi,
P. Fortugno,
Yulia Nefedova,
...
D. Gabrilovich,
G. Colombo,
D. Altieri
|
8 |
2005 |
8 π
|
π’
|
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
9 auth.
N. Zaffaroni,
M. Pennati,
G. Colella,
P. Perego,
R. Supino,
L. Gatti,
...
S. Pilotti,
F. Zunino,
M. Daidone
|
8 |
2002 |
8 π’
|
π
|
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
8 auth.
R. Silvestrini,
E. Benini,
M. Daidone,
S. Veneroni,
P. Boracchi,
V. Cappelletti,
...
G. Fronzo,
U. Veronesi
|
8 |
1993 |
8 π
|
π
|
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
11 auth.
S. Baroni,
S. Romero-Cordoba,
I. Plantamura,
M. Dugo,
E. DβIppolito,
A. Cataldo,
...
G. Cosentino,
V. Angeloni,
A. Rossini,
M. Daidone,
M. Iorio
|
7 |
2016 |
7 π
|
π
|
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
7 auth.
G. Bonadonna,
A. Moliterni,
M. Zambetti,
M. Daidone,
S. Pilotti,
L. Gianni,
...
P. Valagussa
|
7 |
2005 |
7 π
|